Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Long-Term Investments (2022 - 2025)

Cellebrite DI's Long-Term Investments history spans 4 years, with the latest figure at $98.0 million for Q4 2025.

  • Quarterly Long-Term Investments rose 167.64% to $98.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $98.0 million through Dec 2025, up 167.64% year-over-year, with the annual reading at $98.0 million for FY2025, 167.64% up from the prior year.
  • Long-Term Investments came in at $98.0 million for Q4 2025, down from $117.1 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $146.9 million in Q2 2025 to a low of $22.1 million in Q4 2022.
  • The 4-year median for Long-Term Investments is $53.3 million (2023), against an average of $67.2 million.
  • Year-over-year, Long-Term Investments grew 6.69% in 2023 and then soared 167.64% in 2025.
  • Cellebrite DI's Long-Term Investments stood at $22.1 million in 2022, then soared by 30.44% to $28.9 million in 2023, then grew by 26.83% to $36.6 million in 2024, then skyrocketed by 167.64% to $98.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Long-Term Investments are $98.0 million (Q4 2025), $117.1 million (Q3 2025), and $146.9 million (Q2 2025).